EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways

David J Sherman, Lei Liu, Edward L LaGory, Preston Fordstrom, Danielle Pruitt, Jose Barreda, Joy G Cagmat, Jiansong Xie, John Ferbas, Ingrid C Rulifson, Raymond J Deshaies

Cell Reports · 2025-10 · 44 (10) · 116371

DOI: 10.1016/j.celrep.2025.116371 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2025-10. Verfasst von David J Sherman und 10 weiteren Autor:innen. Beteiligte Einrichtung: Research and Development, Amgen, Thousand Oaks, CA 91320, USA. Electronic address: dsherm01@amgen.com. Hauptthemen laut MEDLINE: Triglycerides, Liver, Lipase, Membrane Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 85 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriglyceridesLiverLipaseMembrane ProteinsHumansAnimalsMiceHepatocytesLipoproteins, VLDLLipolysis1-Acylglycerol-3-Phosphate O-AcyltransferaseApolipoproteins BMice, Inbred C57BLMaleAcyltransferasesPhospholipases A2, Calcium-Independent

Stichwörter der Autor:innen

CP: MetabolismPNPLA3lipid dropletslipolysismembrane fluidityphospholipidpolyunsaturated fatty acidssecretory pathwaysteatotic liver diseasetriglyceridevery-low-density lipoproteins

Substanzen

TriglyceridesLipaseMembrane ProteinsPNPLA3 protein, humanLipoproteins, VLDL1-Acylglycerol-3-Phosphate O-AcyltransferaseApolipoproteins BAcyltransferasesPhospholipases A2, Calcium-Independent

Autor:innen und Institutionen

  • Research and Development, Amgen, Thousand Oaks, CA 91320, USA. Electronic address: dsherm01@amgen.com.
  • Research and Development, Amgen, South San Francisco, CA 94080, USA.
  • Research and Development, Amgen, Thousand Oaks, CA 91320, USA.
  • Research and Development, Amgen, Thousand Oaks, CA 91320, USA. Electronic address: rdii2003@gmail.com.

Zitieren

APA

Sherman, D. J., Liu, L., LaGory, E. L., Fordstrom, P., Pruitt, D., Barreda, J., Cagmat, J. G., Xie, J., Ferbas, J., Rulifson, I. C., & Deshaies, R. J. (2025). PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways. Cell Reports, 44(10), 116371. https://doi.org/10.1016/j.celrep.2025.116371

Vancouver

Sherman DJ, Liu L, LaGory EL, Fordstrom P, Pruitt D, Barreda J, et al. PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways. Cell Reports. 2025;44(10):116371. doi:10.1016/j.celrep.2025.116371

BibTeX
@article{Sherman2025,
  author = {Sherman, David J and Liu, Lei and LaGory, Edward L and Fordstrom, Preston and Pruitt, Danielle and Barreda, Jose and Cagmat, Joy G and Xie, Jiansong and Ferbas, John and Rulifson, Ingrid C and Deshaies, Raymond J},
  title = {PNPLA3-I148M is a neomorph that interferes with two primary hepatic triglyceride clearance pathways},
  journal = {Cell Reports},
  year = {2025},
  volume = {44},
  number = {10},
  pages = {116371},
  doi = {10.1016/j.celrep.2025.116371}
}
Kostenlos starten →